PMID- 11350637 OWN - NLM STAT- MEDLINE DCOM- 20010726 LR - 20220321 IS - 1067-1927 (Print) IS - 1067-1927 (Linking) VI - 9 IP - 1 DP - 2001 Jan-Feb TI - Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1. PG - 28-33 AB - Previous studies suggest that normal wound repair requires the regulated production of monocyte and macrophage chemoattractants. The current study examines the role of monocyte chemoattractant protein-1 (MCP-1) in coordinating monocyte recruitment into sites of injury. MCP-1 protein was detected in both incisional and excisional murine wounds, with a peak concentration occurring slightly before maximum macrophage infiltration. Compared to wounds treated with control antibody, wounds treated with a neutralizing monoclonal anti-MCP-1 antibody contained significantly fewer macrophages (8.2 +/- 0.9 vs. 14 +/- 1.7 macrophages per high power field, p < 0.05). Conversely, the addition of recombinant MCP-1 to wounds resulted in a substantial increase in the number of macrophages (107% to 124% increase over untreated wounds, p < 0.01). Because macrophages promote wound healing, the effect of recombinant MCP-1 on the wound healing process was examined. Incisional wounds (n = 12) were either left untreated or treated with vehicle alone, 5 ng recombinant MCP-1 in vehicle, or 50 ng recombinant MCP-1 in vehicle. Wound disruption strength was determined on days 7, 14, 21, and 28 for each group. Wounds treated with MCP-1 exhibited a slight increase in wound disruption strength at nearly all time points but this increase did not reach statistical significance. Addition of 100 ng of MCP-1 to excisional wounds did not have any significant effect on wound reepithelialization. Taken together, the results show that MCP-1 is produced within wounds at physiologic concentrations, and is an important positive regulator of macrophage recruitment into sites of injury. Addition of exogenous MCP-1 to wounds of normal mice yields only modest enhancement of the repair process. FAU - Dipietro, L A AU - Dipietro LA AD - Burn and Shock Trauma Institute, Department of Surgery, Loyola University Medical Center, Maywood, Illinois 60153, USA. ldipiet@luc.edu FAU - Reintjes, M G AU - Reintjes MG FAU - Low, Q E AU - Low QE FAU - Levi, B AU - Levi B FAU - Gamelli, R L AU - Gamelli RL LA - eng GR - GM42577/GM/NIGMS NIH HHS/United States GR - GM55238/GM/NIGMS NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Wound Repair Regen JT - Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society JID - 9310939 RN - 0 (Chemokine CCL2) RN - 0 (Recombinant Proteins) SB - IM MH - Animals MH - Chemokine CCL2/*metabolism/pharmacology MH - Disease Models, Animal MH - Female MH - Macrophages/drug effects/*metabolism MH - Mice MH - Mice, Inbred BALB C MH - Neutrophil Infiltration/drug effects/physiology MH - Recombinant Proteins/pharmacology MH - Reference Values MH - Sensitivity and Specificity MH - Skin/*injuries MH - *Wound Healing/drug effects MH - Wounds, Penetrating/drug therapy/*metabolism EDAT- 2001/05/15 10:00 MHDA- 2001/07/28 10:01 CRDT- 2001/05/15 10:00 PHST- 2001/05/15 10:00 [pubmed] PHST- 2001/07/28 10:01 [medline] PHST- 2001/05/15 10:00 [entrez] AID - wrr028 [pii] AID - 10.1046/j.1524-475x.2001.00028.x [doi] PST - ppublish SO - Wound Repair Regen. 2001 Jan-Feb;9(1):28-33. doi: 10.1046/j.1524-475x.2001.00028.x.